Product Code: BIO066G
Highlights:
The global market for synthetic biology is estimated to increase from $9.5 billion in 2021 to $33.2 billion by 2026, at a compound annual growth rate (CAGR) of 28.4% during the forecast period of 2021-2026.
The global market for synthetic biology enabled products is estimated to increase from $4.7 billion in 2021 to $17.2 billion by 2026, at a CAGR of 29.7% during the forecast period of 2021-2026.
The global market for synthetic biology enabling products is estimated to increase from $3.5 billion in 2021 to $12.3 billion by 2026, at a CAGR of 28.5% during the forecast period of 2021-2026.
Report Scope:
The study scope includes core synthetic biology products (e.g., oligonucleotides, synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-based and cell-free production systems), enabling technologies (e.g., DNA sequencing, DNA synthesis, gene editing, bioinformatics, specialty media) and enabled technologies (e.g., healthcare, industrial chemicals, consumer products, food and beverage, agriculture) that are already commercialized or are forecast to be commercialized through 2026.
Key synthetic biology technologies and products are analyzed to determine present and future market status, as well as forecasted growth from 2021 to 2026. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, patents and market-driving forces is also provided.
BCC Research examines the synthetic biology industry by market segment, including DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries and software; as well as the agriculture; consumer products, cosmetics and skin care, food and beverage, healthcare and industrial chemicals enable product sectors.
The role of key strategic alliances and acquisitions from 2018 to 2020 is discussed. Emerging markets, including synthetic genes, synthetic-biology-enabled drugs and vaccines, genome-edited crops and chassis organisms; as well as metabolically engineered factories for producing synthetic fuels and specialty chemicals, are analyzed, and more than 215 companies in these fields are highlighted.
Report Includes:
- 30 data tables and 99 additional tables
- An up-to-date review and analysis of the global market for synthetic biology within the life science industry
- Analyses of the global market trends, with data from 2019 to 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the global synthetic biology market size, forecasted growth trends, and corresponding market share analysis by product type, end-user industry, and region
- Highlights of the current and future market potential for synthetic biology products and technologies, and areas of focus to forecast this market into various segments and sub-segments
- Description of core synthetic biology products, key enabling technologies, and identify commercial opportunities for product development and competitive strategies
- In-depth assessment of the synthetic biology industry structure, competitors review, and intellectual property landscape
- Information on synthetic biology industry M&A deals, development of commercially viable products and technologies, and other strategic alliances within the industry
- Patent review and analysis of patents granted for synthetic biology technologies, liquid biopsy and sequencing, and gene-editing industry
- Detailed profiles of about 185+ companies within synthetic biology industry. Major players include Agilent Technologies Inc., Eurofins Scientific, GenScript, Merck KGaA, Novozymes A/S, Thermo Fisher Scientific Inc., and Twist Bioscience
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing the Study
- Contribution of the Study and for Whom
- What's New in This Update?
- Scope and Format
- Methodology
- Information Sources
- Geographical Breakdown
- Analyst's Credentials
- BCC Custom Research
- Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Overview
- Synthetic Biology Technologies Covered in this Report
- Value Chain Analysis
- Synthetic Biology Overview
- Development Stage of Synthetic Biology
- Forces Driving the Growth of the Market for Synthetic Biology
- Global Market for Synthetic Biology by End-User Industry
- Product and Technology Life Cycles
- Synthetic Biology Industry
- Impact of COVID-19 on the Global Market for Synthetic Biology
Chapter 4 Technology Background
- Introduction
- Synthetic Biology Defined
- Synthetic Biology History
- Unique Commercially Available Synthetic Biology Products
- Leghemoglobin
- Sitgaliptin
- Hyaline
- PROVEN, a Biological Nitrogen Fertilizer for Corn by Pivot Bio
- Kymriah
- Calyno
- Paradigm Shift in Biology
- Synthetic Biology Technology Overview
- Enabling Technologies
- DNA-Synthesis and DNA-Sequencing Cost Trends
- DNA-Synthesis Technologies
- Microfluidic Technologies
- Next-Generation Sequencing Technologies
- Gene Editing
- Gene Drives
- Bioinformatics Technologies
- Biologic Components and Integrated Systems Technologies
- Synthetic DNA
- BioBrick Parts
- Minimal Genomes and Chassis Organisms
- Enabled Products
- Pathway Engineering
- Research and Development Applications
- Synthetic Biology and the Microbiome
- Synthetic Biology in Biofuels Feedstocks
- Synthetic Biology Microbiome Initiatives
- Current Governance and Regulations
- U.S. Regulations
- International Regulations
Chapter 5 Synthetic Biology Applications
- Enabling Technologies Applications
- Biologic Components and Integrated Systems Applications
- Synthetic Genes
- BioBrick Parts
- Integrated Systems
- Enabled Products Applications
- Pharmaceuticals
- Industrial Biotechnology Applications
- Agricultural Applications
- Data Storage Applications
Chapter 6 Synthetic Biology Industry
- Investment in Synthetic Biology Industry
- Industrial Biotechnology Value Chain
- Industry Structural Forces
- Products and Technology Life Cycle
- Sequencing Instruments Industry
- Long-Read Sequencing Industry
- DNA Synthesis Industry
- Oligos as Therapeutics
- Gene Synthesis Workflow
- Gene Synthesis Value Chain
- Synthetic Gene Market Segments
- Gene-Editing Industry
- Synthetic Biology Organism Design and Foundries Industry
- Software Industry
- Agriculture Industry
- Consumer Products Industry
- Cosmetics and Skin Care Industry
- Food and Beverage Industry
- Healthcare Industry
- Industrial Chemicals Industry
- Cell-Free System Industry
- Industry Acquisitions and Strategic Alliances
Chapter 7 Global Market for Synthetic Biology
- Industry Growth-Driving Forces
- DNA Read, Write and Edit Technologies
- Growing Role of Designer Organisms
- Speeding up of Commercialization Pathways
- Growth in Synthetic Biology Foundries
- Increasing Research and Development Investment by Pharma Companies
- Global Market for Synthetic Biology by End-User Industry
- Research Market
- Healthcare Market
- Industrial Chemicals Market
- Agriculture Market
- Consumer Market
- Food and Beverage Market
- Global Market for Synthetic Biology by Product Type
- Enabling Products Market
- Synthetic Biologic Components Market
- Integrated Systems Market
- Enabled Products Market
- Geographic Markets
- Synthetic Biology Products by Region
- Enabling Products Market by Region
- Core Products Market by Region
- Enabled Products Market by Region
Chapter 8 Patents
- Introduction
- Foundational Patents
- Synthetic Biology Patent Analysis
- Sequencing-Related Patent Issues
- Gene Editing-Related Patents
- Gene Editing Patents: Sangamo Case Study
Chapter 9 Company Profiles
- Key Market Players
- AGILENT TECHNOLOGIES INC.
- AMYRIS INC.
- CODEXIS INC.
- EUROFINS SCIENTIFIC
- GENSCRIPT
- GINKGO BIOWORKS
- MERCK KGAA
- NOVOZYMES A/S
- THERMO FISHER SCIENTIFIC INC.
- TWIST BIOSCIENCE
- VIRIDOS
- Other Players
- 20N LABS INC.
- ABEONA THERAPEUTICS LLC
- ACTIVE MOTIF
- AEMETIS INC.
- AGRIVIDA INC.
- AJINOMOTO CO., INC.
- ALGENUITY
- AMBRX INC.
- AMFORA INC.
- ANSA BIOTECHNOLOGIES INC.
- ANTHEIA INC.
- ARBOR BIOTECHNOLOGIES INC.
- ARCADIA BIOSCIENCES INC.
- ARCTURUS THERAPEUTICS INC.
- ARDRA BIO INC.
- ARZEDA CORP.
- ASTRAZENECA PLC
- ATG BIOSYNTHETICS GMBH
- ATUM
- AVECIA
- AZARGEN BIOTECHNOLOGIES PTY., LTD.
- AZITRA INC.
- BASF AG
- BAYER AG
- BEAM THERAPEUTICS INC.
- BENCHLING
- BENSON HILL BIOSYSTEMS INC.
- BIO BASIC INC.
- BIOGEN INC.
- BIOMAX INFORMATICS AG
- BIOMX LTD.
- BIONEER CORP.
- BIO S&T INC.
- BIOSYNTIA APS
- BLUEBIRD BIO INC.
- BOLT THREADS INC.
- BRISTOL-MYERS SQUIBB CO.
- CALYSTA INC.
- CALYXT INC.
- CARGILL INC.
- CARIBOU BIOSCIENCES INC.
- CRISPR THERAPEUTICS
- CASZYME
- CATALOG TECHNOLOGIES, INC.
- CELLECTIS SA
- CENTRIENT PHARMACEUTICALS
- CHAIN BIOTECHNOLOGY LTD.
- CIBUS INC.
- C-LECTA GMBH
- CODAGENIX INC.
- COLORIFIX LTD.
- CORBION
- CRONOS GROUP
- CROWN LABORATORIES INC.
- DANAHER CORP.
- DEMURIS LTD.
- DNA SCRIPT
- DOVETAIL GENOMICS LLC
- DOWDUPONT INC.
- EDIGENE INC.
- EDITAS MEDICINE INC.
- ELIGO BIOSCIENCE SAS
- ENDLESS WEST
- ENEVOLV INC.
- EPOCH LIFE SCIENCE INC.
- EVONETIX
- EVOLVA SA
- EXXONMOBIL CORP.
- G+FLAS LIFE SCIENCES INC.
- GEA ENZYMES
- GELTOR INC.
- GENEMED SYNTHESIS INC.
- GENERAY BIOTECH CO., LTD.
- GENOMATICA
- GENUS PLC
- GEVO INC.
- GILEAD SCIENCES INC.
- GLAXOSMITHKLINE PLC
- GLOBAL BIOENERGIES
- GLOWEE- UNREASONABLE GROUP
- GLYCOSBIO FOOD SCIENCES
- GLYCOSYN LLC
- GOODYEAR TIRE & RUBBER CO.
- HELIXWORKS TECHNOLOGIES LTD.
- HOMOLOGY MEDICINES INC.
- HORIZON DISCOVERY GROUP PLC
- HUVEPHARMA
- ILLUMINA INC.
- IMPOSSIBLE FOODS INC.
- INDUSTRIAL MICROBES INC.
- INGENZA LTD.
- INOVIO PHARMACEUTICALS INC.
- INSCRIPTA INC.
- INTELLIA THERAPEUTICS INC.
- INTERNATIONAL BUSINESS MACHINES
- JOYN BIO
- KANEKA CORP.
- KWS SAAT SE
- LABGENIUS LTD.
- LANZATECH
- LATTICE AUTOMATION INC.
- LC SCIENCES
- LCY CHEMICAL CORP.
- LGC GROUP
- LOCUS BIOSCIENCES
- LOGICBIO THERAPEUTICS
- LUMEN BIOSCIENCE
- LYGOS INC.
- MEISSA VACCINES, INC.
- MICROSYNBIOTIX
- MICROBYRE, INC.
- MICROSOFT CORP.
- MILIS BIO LTD.
- MODERN MEADOW
- MODULAR GENETICS INC.
- MOLECULAR ASSEMBLIES INC.
- MORPHOSYS AG
- MOTIF INGREDIENTS
- NEW ENGLAND BIOLABS
- NOVARTIS PHARMA AG
- NOVOME BIOTECHNOLOGIES INC.
- NOVVI LLC
- NUCELIS LLC
- NUCLERA NUCLEICS LTD.
- OMEGA BIO-TEK INC.
- ORAGENICS INC.
- OXFORD BIOMEDICA PLC
- PAIRWISE PLANTS INC.
- PFIZER INC.
- PHIO PHARMACEUTICALS CORP.
- PHYTOWELT GREEN TECHNOLOGIES GMBH
- PIVOT BIO
- POSEIDA THERAPEUTICS INC.
- PRECISION BIOSCIENCES INC.
- PROKARIUM HOLDINGS LTD.
- PROMEGA CORP.
- PTC THERAPEUTICS INC.
- RECOMBINETICS INC.
- ROQUETTE FRERES
- ROYAL DSM NV
- SANGAMO THERAPEUTICS INC.
- SAREPTA THERAPEUTICS INC.
- SCARAB GENOMICS LLC
- SENTI BIOSCIENCES
- SHINEGENE MOLECULAR BIO-TECHNOLOGIES INC.
- SIGMA ALDRICH CORP.
- SHERLOCK BIOSCIENCES
- SILICOLIFE LDA.
- SOCATI CORP.
- SPIBER INC.
- STRING BIO
- SUGARLOGIX
- SYNBIO TECHNOLOGIES INC.
- SYNGENTA AG (CHEMCHINA)
- SYNTHEGO CORP.
- SYNLOGIC THERAPEUTICS
- SYNTHACE LTD.
- SYNTHETIC BIOLOGICS INC.
- TAKARA BIO
- TEPHA INC.
- TESELAGEN BIOTECHNOLOGY INC.
- TIERRA BIOSCIENCES
- TOOLGEN
- TRANSCRIPTIC INC.
- TROPIC BIOSCIENCES U.K. LTD.
- TRITON ALGAE INNOVATIONS LTD.
- VEDANTA BIOSCIENCES
- VERSALIS SPA
- VERTEX PHARMACEUTICALS INC.
- VIR BIOTECHNOLOGY INC.
- XYPHOS BIOSCIENCES, INC.
- YIELD10 BIOSCIENCES INC.
- ZIOPHARM ONCOLOGY, INC.
- ZYMERGEN
- ZYMOCHEM INC.